JPWO2022244876A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022244876A5
JPWO2022244876A5 JP2023522741A JP2023522741A JPWO2022244876A5 JP WO2022244876 A5 JPWO2022244876 A5 JP WO2022244876A5 JP 2023522741 A JP2023522741 A JP 2023522741A JP 2023522741 A JP2023522741 A JP 2023522741A JP WO2022244876 A5 JPWO2022244876 A5 JP WO2022244876A5
Authority
JP
Japan
Prior art keywords
peptide
sequence
seq
cell receptor
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023522741A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022244876A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/020990 external-priority patent/WO2022244876A1/ja
Publication of JPWO2022244876A1 publication Critical patent/JPWO2022244876A1/ja
Publication of JPWO2022244876A5 publication Critical patent/JPWO2022244876A5/ja
Pending legal-status Critical Current

Links

JP2023522741A 2021-05-20 2022-05-20 Pending JPWO2022244876A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021085406 2021-05-20
PCT/JP2022/020990 WO2022244876A1 (ja) 2021-05-20 2022-05-20 抗腫瘍剤

Publications (2)

Publication Number Publication Date
JPWO2022244876A1 JPWO2022244876A1 (cg-RX-API-DMAC7.html) 2022-11-24
JPWO2022244876A5 true JPWO2022244876A5 (cg-RX-API-DMAC7.html) 2025-04-17

Family

ID=84141709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023522741A Pending JPWO2022244876A1 (cg-RX-API-DMAC7.html) 2021-05-20 2022-05-20

Country Status (2)

Country Link
JP (1) JPWO2022244876A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022244876A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024163292A1 (en) * 2023-01-30 2024-08-08 Board Of Regents, The University Of Texas System T-cell receptors targeting her2 and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011145615A1 (ja) * 2010-05-18 2011-11-24 タカラバイオ株式会社 多能性幹細胞の製造のための核酸
JP5984113B2 (ja) * 2012-06-11 2016-09-06 学校法人慶應義塾 がん免疫療法
GB201717578D0 (en) * 2017-10-26 2017-12-13 Univ College Cardiff Consultants Ltd Novel T-cell receptor
CN112912391B (zh) * 2018-10-25 2026-07-03 昆士兰医学研究所理事会 T细胞受体及其用途
GB2613715B (en) * 2019-02-20 2023-12-06 Fred Hutchinson Cancer Center Binding proteins specific for RAS neoantigens and uses thereof

Similar Documents

Publication Publication Date Title
US20240390480A1 (en) Nucleic acid vaccines
US20180236044A1 (en) Methods and compositions for rna-guided treatment of hiv infection
AU2025204711A1 (en) Shared neoantigens
ES2545885T3 (es) Eliminación de respuestas inmunitarias contra vectores virales
JP2022031687A (ja) リン酸塩輸送阻害のための化合物及び方法
JP2019506156A (ja) Hiv感染症のrna誘導型治療のための方法及び組成物
JP2015522264A5 (cg-RX-API-DMAC7.html)
KR20180096591A (ko) 광범위 인플루엔자 바이러스 백신
KR20180096592A (ko) 호흡기 세포융합 바이러스 백신
JP2012500001A5 (cg-RX-API-DMAC7.html)
CN101863971A (zh) 转移素衍生物及其用途
JP2008525033A5 (cg-RX-API-DMAC7.html)
JP2015510393A5 (cg-RX-API-DMAC7.html)
JP2019502683A (ja) 癌治療のための併用薬
US11666664B2 (en) Self assembling molecules for targeted drug delivery
JP2024511131A5 (cg-RX-API-DMAC7.html)
US10988522B2 (en) Proteolically resistant cyclotides with angiotensin 1-7 like activity
JP2024542995A5 (cg-RX-API-DMAC7.html)
US20190269711A1 (en) Methods of treating cancer
JP2024503091A5 (cg-RX-API-DMAC7.html)
RU2012146542A (ru) Способ ингибирования репликации вич в клетках млекопитающих и у людей
KR20150039259A (ko) siRNA 전달을 위한 재조합 단백질 및 이를 포함하는 조성물
JP2024504467A5 (cg-RX-API-DMAC7.html)
EP3271020B1 (en) Reversal of latency of retroviruses with a galectin protein
JP2008531463A5 (cg-RX-API-DMAC7.html)